home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
Revolution Medicines Reports First Quarter 2020 Financial Results and Continued Corporate Progress
Revolution Medicines Reports First Quarter 2020 Financial Results and Continued Corporate Progress
Post navigation
Previous Post
Previous
Black Diamond Therapeutics Announces Accepted Abstract for Lead Product Candidate BDTX-189 at American Society of Clinical Oncology 2020
Next Post
Next
Silverback Therapeutics™ to Present Preclinical Data from Lead ImmunoTAC™ Candidate, SBT6050, at Upcoming ASCO Virtual Scientific Program and AACR Virtual Annual Meeting